Takeda Pays Big For De-Risked HutchMed CRC Drug

 
• By Joseph Haas
  
Gold Dollars
Takeda paid substantial upfront cash for the HutchMed drug • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business